1272 - Transurethral Injection of Botulinum Toxin (Botox) into the Bladder Wall for Urinary Incontinence due to Idiopathic Overactive Bladder

Page last updated: 12 April 2018

Application Detail



Description of Medical Service

Transurethral injection of Botox into the inner bladder wall, guided by cystoscopy for the treatment of urinary incontinence.

Description of Medical Condition

diopathic overactive bladder with urinary incontinence

Overactive bladder is caused by a dysfunction in the coordinated mechanisms that provide controlled storage and voiding of urine. This can lead to sudden urges to urinate, which may be difficult to suppress, leading to the involuntary loss of urine (incontinence). Bladder overactivity is also associated with increased pressure within the bladder, which can lead to upper urinary tract complications and renal damage. For idiopathic overactive bladder, the cause of bladder dysfunction is unknown.

Reason for Application


Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


PICO Confirmation

13-14 December 2012
Final Protocol (PDF 162 KB)
Final Protocol (Word 341 KB)

Assessment Report


Public Summary Document

Public Summary Document (PDF 196 KB)
Public Summary Document (Word 83 KB)

Predicted versus Actual

Public Summary Document - July 2017 (PDF 362 KB)
Public Summary Document - July 2017 (Word 147 KB)

Meetings for this Application


16 - 17 August 2012
13 - 14 December 2012




28 November 2013
27 July 2017